Document is current
Any future updates will be listed below
-
Authors
Valentin, Simon
Amalric, Mathieu
Granier, Guillaume
Pequignot, Benjamin
Guervilly, Christophe
Duarte, Kevin
Girerd, Nicolas
Levy, Bruno
Dunand, Paul
Koszutski, Matthieu
Roze, Hadrien
Kimmoun, Antoine http://orcid.org/0000-0002-5443-2074
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 9 June 2023
First Online: 21 June 2023
Declarations
:
: In accordance with French legislation, non-opposition of the patient or their legal representative for use of the data was systematically sought. The study was approved by the ethical committee of Nancy teaching Hospital (N°CO-26). All data were collected into an anonymous computerized database and registered to the electronic data registry of Nancy teaching hospital (N°2022PI050-235). The study was registered in clinical trial registry before the collection and the analysis of the data (ExternalRef removed).
: Not applicable.
: SV, MA, GG, BP, KD, PD, MK, HR, AK declare no competing interests. CG received fees from Xenious, outside the submitted work. NG received honoraria from Astrazeneca, Lilly, Vifor, Bayer, Roche diagnostics, Novartis, Boehringer. BL received fees and grants from Getinge.
